Skip to main content

Table 2 Purposive practice site recruitment strategy

From: Rationale and design of the multinational observational study assessing insulin use: the MOSAIc study

Region

Regional prevalence of diabetes٭

Country

Total population age 20-79 (in thousands)

Country-specific prevalence of diabetes٭

Total number of sites

Specialty sites

General medicine sites

Southeast Asia

8.1%

China

968,975

9.0%

11

2

9

India

737,003

9.2%

26

10

16

Japan

95,341

7.9%

7

4

3

South Korea

36,204

7.7%

6

4

2

     

50

20

30

Europe

10%

Germany

62,810

5.5%

8

2

6

Italy

45,637

5.3%

6

1

5

Russia

109,167

10.0%

12

10

2

Spain

34,896

6.5%

6

1

5

United Kingdom

44,813

5.4%

6

1

5

     

38

15

23

North America

12.1%

Canada

25,141

8.7%

6

1

5

United States

216,805

9.6%

30

6

24

Puerto Rico

2,547

13.3%

4

2

2

     

40

9

31

Middle East/North Africa

10.8%

Abu Dhabi

6,107

19.2%

6

9

31

Israel

4,708

7.6%

6

1

5

Saudi Arabia

17,023

20.0%

6

3

3

Turkey

47,322

8.1%

11

2

9

     

29

7

22

South/Central America

7.8%

Argentina

26,265

5.7%

6

5

1

Brazil

127,995

10.4%

6

1

5

Mexico

69,324

15.9%

6

2

4

     

18

8

10

  

Totals

  

175

59

116

  1. * Age standardized. Obtained from the International Diabetes Federation Diabetes Atlas[17].